Keywords: AGEs; DPP-4; Proximal tubular cells; Inflammation; Diabetic nephropathy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Oxidative stress; Diabetes mellitus; Glyceraldehyde-3-phosphate; AGEs;
Keywords: UV-vis; ultraviolet-visible; MRPs; Maillard reaction products; RPMI; Roswell Park Memorial Institute; FBS; fetal bovine serum; DMSO; dimethyl sulfoxide; 5-HMF; 5-hydroxymethlofurfural; AGEs; advanced glycation end products; Has; heterocyclic amines; M
Keywords: AGEs; advanced glycation end products; CEL; Nε-(carboxyethyl) lysine; CMA; NÏ-(carboxymethyl) arginine; CML; Nε-(carboxymethyl) lysine; H2O2; hydrogen peroxide; HCC; hepato-cellular carcinoma-; HMGB1; high mobility group box-1; NAFLD; nonalcoholic fatt
Keywords: Cholesterol; Obesity; Glucose; Triglycerides; Osteoporosis; Vitamin E; AGEs; advanced glycation end-products; ANOVA; analysis of variance; AUC; area under the curve BMD, bone mineral density; BMI; body mass index; BV/TV; trabecular bone volume; Conn.D; co
Keywords: CKD; chronic kidney disease; DM; diabetes mellitus; T2DM; type 2 diabetes mellitus; ESRD; end-stage renal disease; FPG; fasting plasma glucose; 2â¯h PG; 2â¯h postprandial plasma glucose; HbA1c; hemoglobin A1c; AG; average glucose levels; GA; glycated al
Keywords: PTP1B; protein tyrosine phosphatase 1B; CNS; central nervous system; HFD; high fat diet; NPY; neuropeptide Y; AMPK; 5' AMP-activated protein kinase; BAT; brown adipose tissue; AF; albiflorin; hAMSCs; human adipose tissue-derived mesenchymal stem cells; PP
Keywords: CVDs; cardiovascular diseases; ECs; endothelial cells; VSMCs; vascular smooth muscle cells; HPTMs; histones post-translational modifications; nt; nucleotides; 5-mC; 5-methylcytosine; 5-hmC; 5-hydroxymethylcytosine; CpG; sequence of cytosine followed by a
Keywords: Metabolic syndrome; Algae; Mesenchymal stem cells; Diabetes; Insulin resistance; Obesity; Nutrition; AGEs; advanced glycosylation end products; ALA; alpha-linolenic acid; CHO-FR; rapidly fermentable groups; CHO-FS; slowly fermentable groups; CHO-H; hydrol
Keywords: Migration; Health; Cumulative disadvantage; Ages; Life stages; China;
Keywords: GLP-1; glucagon-like peptide-1; GLP-1RA; glucagon-like peptide-1 receptor agonists; DR; diabetic retinopathy; VEGF; vascular endothelial growth facto; DM; diabetes mellitus; Ops; oscillatory potentials; E4; Exenatide-4; GCL; ganglion cell layer; RGC; Reti
Keywords: Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: AD; Alzheimer's disease; AGEs; advanced glycation end products; BBB; blood-brain barrier; BDNF; brain-derived nerve growth factor; CML; carboxymethyllysine; CMRg; cerebral metabolic rate of glucose; DAMPs; damage-associated molecular patterns; GLUT; gluco
Keywords: AGE; Advanced glycation endproduct; CML; Nε-(carboxymethyl)lysine; CEL; Nε-(carboxyethyl)lysine; MG-H1; 5-hydro-5-methylimidazolone; MMP; Matrix metalloproteinase; TIMP; Tissue inhibitor of metalloproteinase; Type 1 diabetes; AGEs; MMPs; TIMP-1; Cardiov
Keywords: AGEs; advanced glycation end-products; CAD; coronary artery disease; CRP C; reactive protein; CTGF; connective tissue growth factor; DAG; diacyl glycerol; DCM; diabetic cardio-myopathy; DFU; diabetic foot ulcer; eNOS; endothelial nitric oxide synthase; FO
Keywords: OS; oxidative stress; ROS; reactive oxygen species; MG; methylglyoxal; glo 1; glyoxalase-1; glo 2; glyoxalase-2; AGEs; advanced glycation end products; ASD; autism spectrum disorder; GSH; reduced glutathione; cas-3; caspase-3; NeuN; neuronal specific nucl
Keywords: AD; Alzheimer'sdisease; AGEs; advanced glycation end products; CKD; chronic kidney disease; CML; Nε-(carboxylmethyl)-l-lysine; CEL; Nε-(carboxylethyl)-l-lysine; ELISA; enzyme-linked immunosorbent assay; ESRD; end-stagerenal disease; FFQ; food frequenc
Keywords: Aβ; amyloid beta; AD; Alzheimer disease; ADAS-cog; Alzheimer's disease assessment scale-cognitive; AGEs; advanced glycation end products; ARIC; atherosclerosis risk in communities; CLOX-1; clock-drawing executive test; CVR; cerebrovascular responsivene
Keywords: 3-MP; 3-mercaptopyruvate; 3-MST; 3-mercaptopyruvate sulfurtransferase; AAT; aspartate amino transferase; AE1; anion exchanger-1; AGEs; advanced glycation end products; AKI; acute kidney injury; AMPK; AMP-activated protein kinase; AT1; angiotensin receptor
Keywords: AGEs; Advanced glycation end products; ADMA; Asymmetric dimethylarginine; cAMP; Cyclic adenosine monophosphate; DPP-4; Dipeptidyl peptidase 4; GLP-1; Glucagon-like peptide 1; GLP-1R; Glucagon-like peptide 1 receptor; HMGB-1; High mobility group box 1 prot
Keywords: Crocetin; VSMCs; AGEs; Migration; Proliferation; Diabetic vascular complications;
Keywords: AMG; aminoguanidine; ALM; aminoguanidine-limonene equimolar combination; AGEs; advanced glycation end products; LM; limonene; RM; reaction mixture; Aminoguanidine; Limonene; Advanced glycation end products (AGEs); Circular dichroism; Differential scanning
Keywords: AGEs; advanced glycation end-products; CSA; chicken serum albumin; HSA; human serum albumin; LC-ESI-MS; liquid chromatography-electrospray ionization-mass spectrometry; Glycation; Avian; Human; Albumin; Glucose;
Keywords: AGEs; advanced glycation end products; PKC; protein kinase C; DAG; diacylglycerol; ROS; reactive oxygen species; VEGF; vascular endothelial growth factor; VEGFR; vascular endothelial growth factor receptor; ECs; endothelial cells; VSMCs; vascular smooth m
Keywords: ALP; alkaline phosphatase; TRAP; tartrate-resistant acid phosphatase; AGEs; advanced glycation end products; rplp1; 60S acidic ribosomal protein P1; Alloxan; Bone metabolism; Bone model; Diabetes; Fish scales; Glycation of matrix collagen; Hyperglycemia;
Identification of glycated sites in ovalbumin under freeze-drying processing by liquid chromatography high-resolution mass spectrometry
Keywords: AGEs; advanced glycation end products; CD; circular dichroism; CID; collision induced dissociation; DSP; average degree of substitution per peptide molecule; DTT; dl-dithiothreitol; ETD; electron transfer dissociation; FTIR; Fourier Transform Infrared Spe
Keywords: AGEs; advanced alycation and-products; OLE; olive leaf extract; OLE-F1 and OLE-F2; fractions 1 and 2 of olive leaf extract; HT; hydroxytyrosol; DOPAC; 3,4-dihydroxyphenylacetic acid; AG; aminoguanidine; MGO; methylglyoxal; GO; glyoxal; 3-DG; 3-deoxyglucos
Keywords: Olive leaf; Hydroxytyrosol; Antiglycative activity; Dietary advanced glycation endproducts; 1,2-dicarbonyl compounds; Hydroxymethylfurfural; Maillard reaction; Methylglyoxal (PubChem CID: 880); Glyoxal (PubChem CID: 7860); 3-deoxyglucosone (PubChem CID: 1
Keywords: AGEs; advanced glycation end products; GPx; glutathione peroxidase; ROC; receiver operating characteristic analysis; ROS; reactive oxygen species; SOD; superoxide dismutase; Antioxidants; Catalase; Couroupita guianensis; Diabetes; Gold nanoparticles;
Keywords: Pericytes; Endothelial cells; Signaling; Tissue regeneration; AGEs; Advanced glycation end-products; ALP; Alkaline phosphatise; α-SMA; Alpha smooth muscle actin; Ang; Angiopoietin; BM; Basement membrane; CNS; Central nervous system; ECs; Endothelial cell
Keywords: Liver; RAGE; AKT; GSK3; NRF2; AGEs; Advanced glycation end products; RAGE; receptor for advanced glycation end products; ROS; reactive oxygen species; Nfkb1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; PI3K; phosphoinositide 3-ki
Keywords: Butein; Rhus verniciflua; Chronic diseases; Prevention; Treatment; 4E-BP1; eIF4E binding protein 1; ACE; angiotensin converting enzyme; ACTA2; alpha-actin-2; AGEs; advanced glycation end products; ALDH1A3; aldehyde dehydrogenase 1 family member A3; ALL; a
Keywords: Alzheimer's disease; Acetylcholinesterase; Antioxidants; Flavonoids; AGEs; Morris water maze;
Keywords: ABCA1; ATP-binding cassette 1; AGEs; advanced glycation end products; AIF; apoptosis inducing factor; ALDH; aldehyde deshydrogenase; ANT; adenine nucleotide translocator; APAF1; apoptosis protease-activating factor-1; apoB; apolipoprotein B; ARE; antioxid
Keywords: Diabetic cornea; Keratopathy; Neuropathy; Gene therapy; Naltrexone; Insulin; Corneal epithelium; AGEs; Limbal stem cell; Dry eye; Growth factors; Proteinases;
Keywords: AAV; adeno-associated virus; AGEs; accumulation of advanced glycation end products; AAV2; AAV serotype 2; AMD; age-related macular degeneration; BDNF; brain-derived neurotrophic factor; CRISPR; clustered regularly interspaced short palindromic repeats; Ca
Glycation inhibitors extend yeast chronological lifespan by reducing advanced glycation end products and by back regulation of proteins involved in mitochondrial respiration
Keywords: AGEs; advanced glycation end products; CR; calorie restriction; NR; non-calorie restriction; CLS; chronological lifespan; AMG; aminoguanidine; MET; metformin; HYD; hydralazine; RLS; replicative lifespan; Sch9, threonine/threonine; protein kinase; TOR; Tar
Keywords: Maillard reaction products; Dextran sulfate sodium salt; Intestinal barrier; Mast cell; Experimental intestinal inflammation; Food heat treatment; AGEs; advanced glycation end products; AU; arbitrary units; CD; Crohn disease; DSS; dextran sodium sulfate;
Keywords: Diabetic cataract; Glycation; AGEs; Protein aggregation; Aldose reductase; Flavonoids word;
Keywords: ACE; angiotensin-converting enzyme; ACF; airway-centered fibrosis; AEC2; advanced alveolar epithelial cells; AGEs; glycation end products; Ang I; angiotensin I; AT-II; angiotensin II; AT1R; angiotensin Type 1 receptor; α-SMA; α-smooth muscle actin; ATX;
Keywords: Glycation; AGEs; Human serum albumin; Spectroscopic analysis
Keywords: AGEs; advanced glycation end products; β-CE; β-carotene equivalents; CFU; colony-forming unit; DMEM; Dulbecco's modified Eagle's medium; DPBS; Dulbecco's phosphate-buffered saline; DURL; cookies made with Italian whole-grain durum wheat fermented using
Keywords: AA; Acetoacetate; AGEs; Advanced glycation end products; HSA; Human Serum Albumin; GHSA; glycated human serum albumin; 3BHB; 3-β-hydroxybutyrate; CD; Circular Dichroism; Amadori product; Acetoacetate; Ketone body; Glycated HSA; Diabetes mellitus; Prolong
Keywords: Oxidative stress; Reactive oxygen species; Diabetes; Vascular complications; Antioxidants; Mediterranean diet; AGEs; advanced glycation end products; RAGEs; AGE receptors; AT-II; angiotensin-II; CVD; cardiovascular disease; DN; diabetic nephropathy; DR; d
Keywords: AGEs; advanced glycation end products; Ang2; angiopoietin 2; BMI; body-mass index; CVD; cardiovascular disease; ECM; extracellular matrix; FGF; fibroblast growth factor; GDM; gestational diabetes mellitus; HCC; hepatocellular carcinoma; HSPG; heparin sulf
Keywords: RAGE expression; AGES; 6-Hydroxydopamine; Docking; Binding constant; Neurotoxicity
Keywords: AGEs; Oxidative stress; Diet; Cardiometabolic disorder; Aging;
Keywords: Phloroglucinol; Diabetes-Induced Erectile Dysfunction; Sildenafil; CYP3A4; AGEs; Antioxidant
Keywords: Glycotoxins; AGEs; Kidney; Androgens; PCOS
Keywords: DKD; diabetic kidney disease; ATR-FTIR; attenuated total reflectance-Fourier transform infrared; ANN; artificial neural network; HCA; hierarchical cluster analysis; PCA; principal component analysis; ESRD; end-stage renal disease; AGEs; advanced glycation